Literature DB >> 24178429

Coeliac disease: A review of the causative agents and their possible mechanisms of action.

H J Cornell1.   

Abstract

This review outlines the main theories for the aetiology of coeliac disease and presents in more detail the work carried out in an attempt to define the nature of the toxins in wheat gluten. This includes the results of work with synthetic peptides and a discussion of the various assays used.Evidence is presented for an enzyme deficiency in coeliac disease which leads to abnormally high concentrations of certain peptides in the small bowel. These peptides can bring about damage by direct toxic action and by immunological mechanisms.Investigations of activity of synthetic peptides based on the structure of Agliadin appear to be making good progress and point to certain regions of that molecule as being responsible for toxicity. Certain key sequences of amino acids appear to be of fundamental importance to these studies.

Entities:  

Year:  1996        PMID: 24178429     DOI: 10.1007/BF00806090

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  90 in total

1.  Small intestinal biopsy: diagnostic and research value.

Authors:  M SHINER
Journal:  Proc R Soc Med       Date:  1959-01

2.  Gliadin induced changes in the expression of MHC-class II antigens by human small intestinal epithelium. Organ culture studies with coeliac disease mucosa.

Authors:  S Fais; L Maiuri; F Pallone; M De Vincenzi; G De Ritis; R Troncone; S Auricchio
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

3.  Investigation of possible intestinal peptidase deficiency in coeliac disease.

Authors:  H J Cornell; R R Townley
Journal:  Clin Chim Acta       Date:  1973-01-10       Impact factor: 3.786

4.  In vitro pathogenetic studies of coeliac disease. Effects of protein digests on coeliac intestinal biopsy specimens maintained in culture for 48 hours.

Authors:  J Jos; G Lenoir; D Ritis G; J Rey
Journal:  Scand J Gastroenterol       Date:  1975       Impact factor: 2.423

5.  Effect of gliadin and other food peptides on expression of MHC class II molecules by HT-29 cells.

Authors:  T Mothes; U Bendix; C Pfannschmidt; I Lehmann
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

6.  An in-vitro immunological assay for diagnosis of coeliac disease.

Authors:  A Ashkenazi; D Idar; Z T Handzel; M Ofarim; S Levin
Journal:  Lancet       Date:  1978-03-25       Impact factor: 79.321

7.  In vitro determination of small intestinal permeability: demonstration of a persistent defect in patients with coeliac disease.

Authors:  I Bjarnason; T J Peters
Journal:  Gut       Date:  1984-02       Impact factor: 23.059

8.  An alternative mechanism for gluten toxicity in coeliac disease.

Authors:  M M Weiser; A P Douglas
Journal:  Lancet       Date:  1976-03-13       Impact factor: 79.321

9.  Peptide hydrolase activity of human intestinal mucosa in adult coeliac disease.

Authors:  A P Douglas; T J Peters
Journal:  Gut       Date:  1970-01       Impact factor: 23.059

10.  Endomysial antibody: is it the best screening test for coeliac disease?

Authors:  M Ferreira; S L Davies; M Butler; D Scott; M Clark; P Kumar
Journal:  Gut       Date:  1992-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.